DERMAAID Announces "Mild Line" Skincare Series With Niacinamide, Tranexamic Acid and a Heparin-Like Substance for This Autumn

Published: September 29, 2026
DERMAAID Announces "Mild Line" Skincare Series With Niacinamide, Tranexamic Acid and a Heparin-Like Substance for This Autumn

DERMAAID, a skincare brand from pdc that offers first aging care (starting to care for your skin in a way suited to your age) for people who are beginning to notice skin concerns, is preparing a new series for this autumn. The "Mild Line" will consist of the Triple Active Mild Lotion and the Triple Active Mild Cream.

Detailed product information is scheduled to be officially announced in late October 2026. The release date, price, and where to buy will be shared at that time.

Development Background

DERMAAID has been used by many customers as a skincare series that approaches three concerns: whitening (suppressing the production of melanin to prevent spots and freckles), wrinkle improvement, and prevention of rough skin.

At the same time, customer feedback included comments such as "I want a series I can use even when my skin is easily unsettled" and "I want to keep up with aging care (skincare suited to your age), but I hesitate to use it when my skin is unstable."

To respond to these voices, the Mild Line was developed as a new option that keeps the aging care approach DERMAAID is known for while aiming for a gentler feel in use.

The development team paid particular attention to the rough-skin-prevention ingredient. The Basic Line uses the active ingredient panthenol (D-panthenyl alcohol), while the Mild Line newly adds a heparin-like substance, with its moisturizing function in mind. Combined with tranexamic acid, a whitening active ingredient, and niacinamide, a wrinkle-improving active ingredient, the line is meant to support multifaceted skincare while remaining gentle on the skin.

Rather than doing aging care only when the skin is in good condition, the aim is to offer aging care that can be continued without strain even when the skin is dry and prone to instability. The Mild Line grew out of that idea.

All are quasi-drugs. From left: Triple Active Lotion N (sales name), Triple Active Cream N (sales name), Triple Active Mild Lotion, Triple Active Mild Cream

About the Mild Line

Two items are planned for the Mild Line: a lotion and a cream. The release date, price, and sales information will be announced in the official release scheduled for late October 2026.

YouTube Collaboration

Kazunosuke, beauty chemist

DERMAAID has teamed up with Kazunosuke, a beauty chemist. In a YouTube video scheduled to go live around 9:00 PM on September 29, he introduces the renewed DERMAAID Basic Line and the new Mild Line ahead of their release.

Kazunosuke has featured the DERMAAID Basic Line before. Attention grew afterward, mainly through social media and word of mouth, and it became an opportunity for many customers to learn about the brand.

In this video, he shares his take on the points of the DERMAAID renewal from the perspective of someone who has long analyzed and shared information about skincare ingredients. The content is aimed both at people already using DERMAAID and at those considering trying it.

Kazunosuke's YouTube channel

About DERMAAID

DERMAAID is a first-aging-care brand created for people whose skin concerns are complex and never-ending. It has drawn attention as a Japan-first brand: according to a survey by TPC Marketing Research Co., Ltd. (as of July 8, 2024), it offers the first quasi-drug in Japan containing a wrinkle-improving active ingredient formulated with three active ingredients: niacinamide, tranexamic acid, and D-panthenyl alcohol.

The brand offers quasi-drug skincare at a price range that is easy to pick up in stores. The name was chosen out of a wish to help people who are struggling with signs of aging, or who are just starting to. "DERMA" is a coined word derived from dermatology (the science of skin), and "AID" is the English word meaning help, support, or assistance.